BMSC-EVs can transfer MALAT1 into osteosarcoma cells, thus increasing the expression of MALAT1 and NRSN2, reducing the expression of miR-143, and activating Wnt/β-catenin pathway in osteosarcoma cells (26). The gene discussed is NRSN2; the disease is osteosarcoma.